Status: current, Sufficiently defined by necessary conditions definition status. Date: 12-Apr 2023. Module: SNOMED CT United Kingdom pathology and laboratory medicine production content extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 23011000237116 | CA19-9 (cancer antigen 19-9) arbitrary concentration in serum | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom pathology and laboratory medicine production content extension module |
| 30831000237112 | Arbitrary concentration of cancer antigen 19-9 in serum (observable entity) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom pathology and laboratory medicine production content extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Arbitrary concentration of cancer antigen 19-9 in serum (observable entity) | Is a | Observable entity | false | Inferred relationship | Existential restriction modifier | ||
| Arbitrary concentration of cancer antigen 19-9 in serum (observable entity) | Direct site | Serum specimen | true | Inferred relationship | Existential restriction modifier | 1 | |
| Arbitrary concentration of cancer antigen 19-9 in serum (observable entity) | Property | Arbitrary concentration | true | Inferred relationship | Existential restriction modifier | 1 | |
| Arbitrary concentration of cancer antigen 19-9 in serum (observable entity) | Inheres in | Serum | true | Inferred relationship | Existential restriction modifier | 1 | |
| Arbitrary concentration of cancer antigen 19-9 in serum (observable entity) | Is a | Tumour marker levels | true | Inferred relationship | Existential restriction modifier | ||
| Arbitrary concentration of cancer antigen 19-9 in serum (observable entity) | Technique | Measurement technique | true | Inferred relationship | Existential restriction modifier | 1 | |
| Arbitrary concentration of cancer antigen 19-9 in serum (observable entity) | Component | Cancer antigen 19-9 | true | Inferred relationship | Existential restriction modifier | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR